Baseline characteristics
| Characteristic | Pravastatin group (n=34) | Placebo group (n=36) | p Value |
| Age (years) | 56.3 (1.6) | 57.2 (1.3) | NS |
| Sex (M/F) | 27/7 | 31/5 | NS |
| Smoking history | 28 (82%) | 31 (86%) | NS |
| Previous consumption (n/day) | 15.3 (2.5) | 19.5 (2.6) | NS |
| Duration of smoking (years) | 27.5 (2.6) | 29.8 (11.1) | NS |
| History of MI | 7 (21%) | 14 (39%) | NS |
| History of PTCA/CABG | 0 (0%) | 0 (0%) | NS |
| History of CVA | 1 (3%) | 1 (3%) | NS |
| History of hypertension | 10 (29%) | 11 (30%) | NS |
| Diabetes | 1 (3%) | 5 (14%) | NS |
| Vessel to be dilated (LAD/Cx) | 25/9 | 21/15 | NS |
Values are mean (SEM) or n (%).
CABG, coronary artery by pass graft; Cx, circumflex coronary artery; CVA, cerebrovascular accident; LAD, left anterior descending coronary artery; M/F, male/female; MI, myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty.